Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study [NA]

View source ↗

Summary

Clinical trial update for SloMo2 describes an implementation, effectiveness, and cost-effectiveness study in schizophrenia and affective psychosis, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: King's College London | Conditions: Schizophrenia Spectrum and Other Psychotic Disorders, Affective Psychoses | NA | Status: RECRUITING